[1]SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30.
|
[2]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.
|
[3]ANDRIULLI A,FESTA V,BOTTERI E,et al.Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer:a meta-analysis of prospective studies[J].Ann Surg Oncol,2012,19(5):1644-1662.
|
[4]DAVIS JL,PANDALAI PK,RIPLEY RT,et al.Expanding surgical treatment of pancreatic cancer:the role of regional chemotherapy[J].Pancreas,2012,41(5):678-684.
|
[5]DRAGOVICH T.Is there a case for personalized therapy of pancreatic cancer?[J].Clin Adv Hematol Oncol,2012,10(5):344-345.
|
[6]PORUK KE,FIRPO MA,ADLER DG,et al.Screening for pancreatic cancer:why,how,and who?[J].Ann Surg,2013,257(1):17-26.
|
[7]HARTWIG W,VOLLMER CM,FINGERHUT A,et al.Extended pancreatectomy in pancreatic ductal adenocarcinoma:definition and consensus of the International Study Group for Pancreatic Surgery(ISGPS)[J].Surgery,2014,156(1):1-14.
|
[8]Japan Pancreas Society.General rules for cancer of the pancreas[M].3rd ed.Tokyo:Kanehara Shuppan,1986.
|
[9]ISHIKAWA O,OHHIGASHI H,SASAKI Y,et al.Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head[J].Ann Surg,1988,208(2):215-220.
|
[10]MANABE T,OHSHIO G,BABA N,et al.Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas[J].Cancer,1989,64(5):1132-1137.
|
[11]HENNE-BRUNS D,VOGEL I,LTTGES J,et al.Ductal adenocarcinoma of the pancreas head:survival after regional versus extended lymphadenectomy[J].Hepatogastroenterology,1998,45(21):855-866.
|
[12]MUKAIYA M,HIRATA K,SATOH T,et al.Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas:retrospective multi-institutional analysis in Japan[J].World J Surg,1998,22(3):248-252.
|
[13]YEO CJ,BASTIDAS JA,SCHMIEG RE Jr,et al.Pancreatic structure and glucose tolerance in a longitudinal study of experimental pancreatitis-induced diabetes[J].Ann Surg,1989,210(2):150-158.
|
[14]YEO CJ,CAMERON JL,LILLEMOE KD,et al.Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma,part 2:randomized controlled trial evaluating survival,morbidity,and mortality[J].Ann Surg,2002,236(3):355-366.
|
[15]PEDRAZZOLI S,DICARLO V,DIONIGI R,et al.Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas:a multicenter,prospective,randomized study.Lymphadenectomy Study Group[J].Ann Surg,1998,228(4):508-517.
|
[16]POPIELA T,KEDRA B,SIERZEGA M,et al.Does extended lymphadenectomy improve survival of pancreatic cancer patients?[J].Acta Chir Belg,2002,102(2):78-82.
|
[17]FARNELL MB,PEARSON RK,SARR MG,et al.A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J].Surgery,2005,138(4):618-628.
|
[18]Japan Pancreas Society.Classification of pancreatic carcinoma[M].2nd English ed.Tokyo:Kanehara Shuppan,2003.
|
[19]TEMPERO MA,MALAFA MP,BEHRMAN SW,et al.Pancreatic adenocarcinoma,version 2.2014:featured updates to the NCCN guidelines[J].J Natl Compr Canc Netw,2014,12(8):1083-1093.
|
[20]TOL JA,GOUMA DJ,BASSI C,et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma:a consensus statement by the International Study Group on Pancreatic Surgery(ISGPS)[J].Surgery,2014,156(3):591-600.
|
[21]CONNOR S,BOSONNET L,GHANEH P,et al.Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status[J].Br J Surg,2004,91(12):1592-1599.
|
[22] Group of Pancreas Surgery,Chinese Society of Surgery,Chinese Medical Association.Guidelines for the management of pancreatic cancer(2014)[J].J Clin Hepatol,2014,30(12):1240-1245.(in Chinese)中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南(2014)[J].临床肝胆病杂志,2014,30(12):1240-1245.
|
[23]PAIELLA S,SANDINI M,GIANOTTI L,et al.The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer:a systematic review and meta-analysis[J].Eur J Surg Oncol,2016,42(5):616-624.
|
[24]KAWABATA Y,TANAKA T,ISHIKAWA N,et al.Modified total meso-pancreatoduodenum excision with pancreaticoduodenectomy as a mesopancreatic plane surgery in borderline resectable pancreatic cancer[J].Eur J Surg Oncol,2016,42(5):698-705.
|
[1] | Liang ZHANG, Hao LI, Shanhong TANG. Thoughts on the diagnosis and treatment of hepatic encephalopathy associated with blood ammonia in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2942-2945. doi: 10.3969/j.issn.1001-5256.2023.12.028 |
[2] | Yijing ZHU, Wei LI, Shousong ZHAO. Research advances in the association between sarcopenia and hepatic encephalopathy in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(3): 671-676. doi: 10.3969/j.issn.1001-5256.2023.03.030 |
[3] | Humin ZHU, Xudong LIU, Lu HUANG, Pinhua LI, Tiexiong WU, Huazhen PANG. Expression levels of gastrointestinal hormones in the progression of liver fibrosis in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2021, 37(10): 2364-2368. doi: 10.3969/j.issn.1001-5256.2021.10.021 |
[4] | Cheng Na, Yang Jing. Association of estrogen receptor α gene polymorphisms with hepatitis B cirrhosis[J]. Journal of Clinical Hepatology, 2020, 36(1): 186-189. doi: 10.3969/j.issn.1001-5256.2020.01.044 |
[5] | Tang ShiHao, Chen Hui, Han GuoHong. Association between gut microbiota and hepatic encephalopathy in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2019, 35(5): 1109-1113. doi: 10.3969/j.issn.1001-5256.2019.05.041 |
[6] | Chinese Society of Hepatology, Chinese Medical Association. Guidelines on the management of hepatic encephalopathy in cirrhosis[J]. Journal of Clinical Hepatology, 2018, 34(10): 2076-2089. doi: 10.3969/j.issn.1001-5256.2018.10.007 |
[7] | Wang JiuHeng, Li GuiYu, Wang YunZhong, Xu ChengJun, Zhao TieJian. A case of young female with cryptogenic cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(5): 948-949. doi: 10.3969/j.issn.1001-5256.2016.05.031 |
[8] | Wang MaoRong. Paying attention to nutritional management of hepatic encephalopathy in patients with liver cirrhosis: introduction to ISHEN consensus[J]. Journal of Clinical Hepatology, 2013, 29(9): 649-651. doi: 10.3969/j.issn.1001-5256.2013.09.004 |
[9] | Mou XiaoHui. Management of spontaneous bacterial peritonitis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1015-1018. |
[10] | Duan WeiJia, You Hong. Therapy advances in primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(6): 581-583. |
[11] | Hu YuLin, Quan XiangLan. Research state and prospect of hyponatremia in cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(3): 330-332. |
[12] | Xu ZhengJie, Zhong Yan, Liu Jiao, Fan JianGao. Analysis of characteristics of 58 cases of cryptic cirrhosis in Shanghai area [J]. Journal of Clinical Hepatology, 2010, 26(3): 264-266. |
[13] | Wang Yu, Po YunFeng, Xu XianJi. A retrospective analysis of 74 patients with hipatic encephalopathy[J]. Journal of Clinical Hepatology, 2005, 21(3): 166-167. |
[15] | Xiang HaiPing, Jin RongHua, Guo XinHui, Chen YiSen, Gao JiRong, Jiang TaiYi. The GH resistance of liver cirrhosis improved by rGH therapy.[J]. Journal of Clinical Hepatology, 2004, 20(2): 93-95. |
[17] | Mao JunLing, Chen YuBo, Xia DongMing, Zhang YanHua. Clinical significance of serumthyroxine determination in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2001, 17(2): 101-102. |